Concord Biotech IPO Details
IPO Date	August 4, 2023 to August 8, 2023
Listing Date	August 18, 2023
Face Value	₹1 per share
Issue Price Band	₹705 to ₹741 per share
Issue Price Final	₹741 per share
Lot Size	20 Shares
Sale Type	Offer For Sale
Total Issue Size	2,09,25,652 shares
(aggregating up to ₹1,550.52 Cr)
Employee Discount	₹70.00
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Post Issue	10,46,16,204 shares
Concord Biotech IPO Reservation
Concord Biotech IPO offers total 2,09,25,652 shares. Out of which 1,04,57,825 (49.98%) allocated to QIB, 41,83,130 (19.99%) allocated to QIB, 31,37,348 (14.99%) allocated to NII, 73,20,479 (34.98%) allocated to RII and 62,74,695 (29.99%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	1,04,57,825 (49.98%)	NA
NII (HNI) Shares Offered	31,37,348 (14.99%)	NA
Retail Shares Offered	73,20,479 (34.98%)	3,66,023
Employee Shares Offered	10,000 (0.05%)	NA
Total Shares Offered	2,09,25,652 (100.00%)	
Investor Category Reservations
Application Category	Maximum Bidding Limits	Bidding at Cut-off Price Allowed
Only RII	Up to Rs 2 Lakhs	Yes
Only sNII	Rs 2 Lakhs to Rs 10 Lakhs	No
Only bNII	Rs 10 Lakhs to NII Reservation Portion	No
Only employee		Yes
Employee + RII/NII	
Employee limit: (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)
If applying as RII: Upto Rs. 2 lakhs
If applying as NII: sNII > Rs. 2 lakhs and upto Rs. 10 lakhs and bNII > Rs. 10 lakhs
Yes for Employee and RII/NII
Concord Biotech IPO Anchor Investors Details
Concord Biotech IPO raises ₹464.95 crore from anchor investors. Concord Biotech IPO Anchor bid date is August 3, 2023. Concord Biotech IPO Anchor Investors list

Bid Date	August 3, 2023
Shares Offered	62,74,695
Anchor Portion Size (In Cr.)	464.95
Anchor lock-in period end date for 50% shares (30 Days)	September 10, 2023
Anchor lock-in period end date for remaining shares (90 Days)	November 9, 2023
Concord Biotech IPO Timeline (Tentative Schedule)
Concord Biotech IPO opens on August 4, 2023, and closes on August 8, 2023.

IPO Open Date	Fri, Aug 4, 2023
IPO Close Date	Tue, Aug 8, 2023
Tentative Allotment	Fri, Aug 11, 2023
Initiation of Refunds	Mon, Aug 14, 2023
Credit of Shares to Demat	Thu, Aug 17, 2023
Tentative Listing Date	Fri, Aug 18, 2023
Cut-off time for UPI mandate confirmation	5 PM on Tue, Aug 8, 2023
Concord Biotech IPO Lot Size
Investors can bid for a minimum of 20 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	20	₹14,820
Retail (Max)	13	260	₹1,92,660
S-HNI (Min)	14	280	₹2,07,480
S-HNI (Max)	67	1,340	₹9,92,940
B-HNI (Min)	68	1,360	₹10,07,760
Concord Biotech IPO Promoter Holding
Sudhir Vaid and Ankur Vaid are the Company Promoters.
Promoter Holding Pre Issue	44.08%
Promoter Holding Post Issue	44.08%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Concord Biotech Ltd.
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.

Concord Biotech has a Global presence. They are supplying their products to over 70 countries including the USA, India, Europe, and Japan.

The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.

Concord manufactures fermentation and semi-synthetic-based products in therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.

Company Financials
Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Total Income	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus			
Total Borrowing	86.35	60.59	31.24
Amount in ₹ Crore
Key Performance Indicator (KPI)
The market capitalization of Concord Biotech IPO is ₹7752.06 Cr.

KPI	Values
ROE	20.06%
ROCE	24.27%
RoNW	20%
Check Concord Biotech IPO Peer Comparison here.
Pre IPO	Post IPO
EPS Rs	20.79	
P/E (x)	32.29	
Concord Biotech IPO Review
[Dilip Davda]  The company is an Indian biopharma company with many niche products. It marked a setback in the bottom line for FY22 but posted growth in the top line for the reported three fiscals. Based on FY23 financial performance, the issue appears fully priced. This entire issue is by way of OFS and no fund is going to the company. Well-informed investors may park funds for the medium to long-term rewards. Read detail review...

Concord Biotech IPO Subscription Status (Bidding Detail)
The Concord Biotech IPO is subscribed 24.87 times on August 8, 2023 7:02:00 PM (Day 3). The public issue subscribed 3.78 times in the retail category, 67.67 times in the QIB category, and 16.99 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	67.67	41,83,130	28,30,64,540
NII	16.99	31,37,348	5,33,05,680
    bNII (bids above ₹10L)	19.3	20,91,565	4,03,68,000
    sNII (bids below ₹10L)	12.37	10,45,783	1,29,37,680
Retail	3.78	73,20,479	2,76,82,480
Employee	24.48	10,000	2,44,840
Total	24.87	1,46,50,957	36,42,97,540
Total Application : 12,64,369

Concord Biotech IPO Prospectus
  ›  Concord Biotech IPO DRHP
  ›  Concord Biotech IPO RHP
  ›  Anchor Investors in Concord Biotech IPO
  ›  Concord Biotech IPO Final Prospectus
Concord Biotech IPO Listing Details
Listing Date	August 18, 2023
BSE Script Code	543960
NSE Symbol	CONCORDBIO
ISIN	INE338H01029
Final Issue Price	₹741 per share
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹741.00	₹741.00
Open	₹900.05	₹900.05
Low	₹900.00	₹900.05
High	₹987.05	₹987.70
Last Trade	₹941.85	₹942.80